company background image
AQA logo

Advanced Medical Solutions Group DB:AQA Stock Report

Last Price

€2.46

Market Cap

€534.9m

7D

0%

1Y

3.4%

Updated

06 Feb, 2025

Data

Company Financials +

Advanced Medical Solutions Group plc

DB:AQA Stock Report

Market Cap: €534.9m

AQA Stock Overview

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. More details

AQA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health4/6
Dividends4/6

Rewards

Earnings are forecast to grow 20.82% per year

Analysts in good agreement that stock price will rise by 28.4%

Risk Analysis

Profit margins (8.5%) are lower than last year (15.2%)


My Notes

Capture your thoughts, links and company narrative

Advanced Medical Solutions Group plc Competitors

Paul Hartmann

DB:PHH2

€824.0m

Stratec

XTRA:SBS

€440.0m

Drägerwerk KGaA

XTRA:DRW3

€989.6m

Eckert & Ziegler

XTRA:EUZ

€1.2b

Price History & Performance

Summary of share price highs, lows and changes for Advanced Medical Solutions Group
Historical stock prices
Current Share PriceUK£2.46
52 Week HighUK£3.02
52 Week LowUK£2.06
Beta0.71
1 Month Change7.89%
3 Month Change-4.65%
1 Year Change3.36%
3 Year Change-26.79%
5 Year Change-24.19%
Change since IPO1,916.39%

Recent News & Updates

Recent updates

Shareholder Returns

AQADE Medical EquipmentDE Market
7D0%3.6%0.5%
1Y3.4%-0.9%15.3%

Return vs Industry: AQA exceeded the German Medical Equipment industry which returned -4.7% over the past year.

Return vs Market: AQA underperformed the German Market which returned 13.7% over the past year.

Price Volatility

Is AQA's price volatile compared to industry and market?
AQA volatility
AQA Average Weekly Movement6.5%
Medical Equipment Industry Average Movement6.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: AQA has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: AQA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19911,500Chris Meredithwww.admedsol.com

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names.

Advanced Medical Solutions Group plc Fundamentals Summary

How do Advanced Medical Solutions Group's earnings and revenue compare to its market cap?
AQA fundamental statistics
Market cap€534.90m
Earnings (TTM)€13.33m
Revenue (TTM)€157.02m

40.1x

P/E Ratio

3.4x

P/S Ratio

Is AQA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AQA income statement (TTM)
RevenueUK£131.11m
Cost of RevenueUK£59.73m
Gross ProfitUK£71.38m
Other ExpensesUK£60.25m
EarningsUK£11.13m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 19, 2025

Earnings per share (EPS)0.051
Gross Margin54.45%
Net Profit Margin8.49%
Debt/Equity Ratio32.7%

How did AQA perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

47%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 20:00
End of Day Share Price 2025/02/06 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advanced Medical Solutions Group plc is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Julie SimmondsCanaccord Genuity
Keith RedpathCavendish